Literature DB >> 23725593

High-temperature, high-pressure hydrothermal synthesis and characterization of a salt-inclusion mixed-valence uranium(V,VI) silicate: [Na9F2][(U(V)O2)(U(VI)O2)2(Si2O7)2].

Yu-Chih Chang1, Wen-Jung Chang, Sophie Boudin, Kwang-Hwa Lii.   

Abstract

A salt-inclusion mixed-valence uranium(V,VI) silicate, [Na9F2][(U(V)O2)(U(VI)O2)2(Si2O7)2], was synthesized under hydrothermal conditions at 585 °C and 160 MPa and structurally characterized by powder and single-crystal X-ray diffraction (XRD). The valence states of uranium were established by U 4f X-ray photoelectron spectroscopy (XPS). The structure contains two-dimensional (2D) sheets of uranyl disilicate with the composition [UO2Si2O7], which are connected by U(1)(V)O6 tetragonal bipyramids to form thick layers. The Na(+) cations are located at sites in the intralayer and interlayer regions. In addition to Na(+) cations, the interlayer region also contains F(-) anions such that infinite chains with the formula FNa1/1Na4/2 are formed. The same type of chain was observed in K2SnO3. The title compound is not only the first example of salt-inclusion metal silicate synthesized under high-temperature, high-pressure hydrothermal conditions, as well as the first salt-inclusion mixed-valence uranium silicate, but it is also the first mixed-valence uranium(V,VI) silicate in the literature. Crystal data: [Na9F2][(U(V)O2)(U(VI)O2)2(Si2O7)2], triclinic, P1 (No. 2), a = 5.789(1) Å, b = 7.423(2) Å, c = 12.092(2) Å, α = 90.75(3)°, β = 96.09(3)°, γ = 90.90(3)°, V = 516.5(2) Å(3), Z = 1, R1 = 0.0241, and wR2 = 0.0612.

Entities:  

Year:  2013        PMID: 23725593     DOI: 10.1021/ic400854j

Source DB:  PubMed          Journal:  Inorg Chem        ISSN: 0020-1669            Impact factor:   5.165


  1 in total

1.  Understanding the Stability of Salt-Inclusion Phases for Nuclear Waste-forms through Volume-based Thermodynamics.

Authors:  Emily E Moore; Vancho Kocevski; Christian A Juillerat; Gregory Morrison; Mingyang Zhao; Kyle S Brinkman; Hans-Conrad Zur Loye; Theodore M Besmann
Journal:  Sci Rep       Date:  2018-10-17       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.